A- A+ facebook twitter email print Column: Is Gilead ripping us off with a COVID-19 treatment topping $3,000? Los Angeles Times June 29, 2020, 10:53 pm The drug maker says its high price for remdesivir is warranted because hospitalization would cost thousands of dollars more.
